Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: The Prolonged Effect of Consumption of a Partially Hydrolyzed Infant Formula During the First 6 Months of Life on the Development of Allergic Manifestations At 5 Years of Age

View source ↗

Summary

This completed clinical trial from FrieslandCampina evaluated whether feeding infants a partially hydrolyzed formula in the first 6 months affects allergic mani…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Partially hydrolyzed infant formula (partially hydrolyzed infant formula)

Snippet

Sponsor: FrieslandCampina | Conditions: Allergy | Status: COMPLETED